Thalidezine is primarily used in research settings for its potential cardiovascular effects. It has been studied for its ability to modulate vascular tone, showing vasodilatory properties that may be beneficial in conditions involving blood flow restriction. Due to its action on smooth muscle relaxation, it has been explored as a lead compound in the development of treatments for hypertension and angina. Additionally, Thalidezine exhibits antiplatelet activity, which may help in preventing abnormal blood clot formation, making it of interest in anti-thrombotic therapy research. Its use remains largely experimental, with ongoing studies to evaluate efficacy and safety in preclinical models.